Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | SRC | P12931 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9016492 | 0.82 | CYP1A2 (0.53) | CYP1A2CYP2D6LMNAMAPK1GAA | |
| SCHEMBL18526631 | 0.80 | CYP1A2 (0.45) | CYP1A2KMT2ACYP2D6LMNAMAPK1 | |
| SCHEMBL9016418 | 0.79 | CYP1A2 (0.47) | CYP1A2KMT2ACYP2D6LMNAMAPK1 | |
| SCHEMBL9016427 | 0.78 | GAA (0.55) | CYP1A2KMT2ALMNAGAATSHR | |
| SCHEMBL9016539 | 0.71 | CYP1A2 (0.46) | CYP1A2KMT2ACYP2D6LMNAMAPK1 | |
| SCHEMBL27556320 | 0.70 | CYP1A2 (0.57) | CYP1A2KMT2ACYP2D6LMNAMAPK1 | |
| SCHEMBL27085755 | 0.70 | CYP1A2 (0.45) | CYP1A2KMT2ACYP2D6LMNAMAPK1 | |
| SCHEMBL25404016 | 0.69 | CYP1A2 (0.61) | CYP1A2KMT2ACYP2D6LMNAMAPK1 | |
| SCHEMBL9448933 | 0.69 | KMT2A (0.62) | CYP1A2KMT2ALMNATSHRMEN1 | |
| SCHEMBL9448931 | 0.69 | KMT2A (0.62) | CYP1A2KMT2ALMNATSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2328865-B1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2017-05-31 | — | — | EP | disclosed |